U.S., Feb. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07429383) titled 'Validity and Reliability of the Hypertonia Assessment Tool (HAT) in Stroke Patients' on Feb. 17.
Brief Summary: In this study, the validity and reliability of the Hypertonia Assessment Tool (HAT), which has previously been validated in the pediatric cerebral palsy (CP) population, will be evaluated in adult individuals who have experienced a stroke. The HAT is a specific clinical instrument designed to differentiate subtypes of hypertonia, including spasticity, dystonia, and rigidity.
Accurate classification of hypertonia subtypes following stroke is crucial for guiding rehabilitation strategies. However, the HAT has not yet been v...